{
    "eid": "2-s2.0-85041909885",
    "title": "Updating the recommendations for treatment of tardive syndromes: A systematic review of new evidence and practical treatment algorithm",
    "cover-date": "2018-06-15",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Neurology",
            "@code": "2808",
            "@abbrev": "NEUR"
        },
        {
            "@_fa": "true",
            "$": "Neurology (clinical)",
            "@code": "2728",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Evidence-based guideline",
        "Tardive dyskinesia",
        "Tardive syndromes",
        "Treatment algorithm"
    ],
    "authors": [
        "Roongroj Bhidayasiri",
        "Onanong Jitkritsadakul",
        "Joseph H. Friedman",
        "Stanley Fahn"
    ],
    "citedby-count": 74,
    "ref-count": 72,
    "ref-list": [
        "Evidence-based guideline: treatment of tardive syndromes: report of the Guideline Development Subcommittee of the American Academy of Neurology",
        "Levels of evidence: taking neurology to the next level",
        "Summary of Evidence-based Guideline for Clinicians: Treatment of Tardive Syndromes",
        "Summary of Evidence-based Guideline for Patients and Their Families: Treating and Managing Tardive Syndromes",
        "Classification and treatment of tardive syndromes",
        "Spectrum of tardive syndromes: clinical recognition and management",
        "Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugs",
        "The natural history of tardive dystonia. A long-term follow-up study of 107 cases",
        "Tardive akathisia: an analysis of clinical features and response to open therapeutic trials",
        "Clinical Practice Guideline Process Manual",
        "Amendments to the 2011 American Academy of Neurology Clinical Practice Guideline Process Manual",
        "Effect of antipsychotic type and dose changes on tardive dyskinesia and parkinsonism severity in patients with a serious mental illness: The Curacao extrapyramidal syndromes study XII",
        "Long-term treatment of tardive dyskinesia with haloperidol and tetrabenazine",
        "Tetrabenazine treatment for tardive dyskinesia: assessment by randomized videotape protocol",
        "Tetrabenazine for tardive tremor in elderly adults: a prospective follow-up study",
        "Dopamine depleters in the treatment of hyperkinetic movement disorders",
        "Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders",
        "Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial",
        "Randomized controlled trial of deutetrabenazine for tardive dyskinesia: the ARM-TD study",
        "NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: a randomized, double-blind, placebo-controlled study",
        "KINECT 3: a phase 3 randomized, double-blind, placebo-controlled trial of valbenazine for tardive dyskinesia",
        "Tolerability of Valbenazine (NBI-98854) in subjects with tardive dyskinesia and a diagnosis of schizophrenia or mood disorder",
        "Efficient trial design - FDA approval of valbenazine for tardive dyskinesia",
        "Treatment of tardive dystonia induced by antipsychotics, old and new",
        "Management of tardive syndromes with clozapine: a case series",
        "Rapid improvement of tardive dyskinesia with tetrabenazine, clonazepam and clozapine combined: a naturalistic long-term follow-up study",
        "Effects of zonisamide on tardive dyskinesia: a preliminary open-label trial",
        "Long-term efficacy and tolerability of bilateral pallidal stimulation to treat tardive dyskinesia",
        "Long-term follow-up of bilateral subthalamic deep brain stimulation for refractory tardive dystonia",
        "Temporal profile of improvement of tardive dystonia after globus pallidus deep brain stimulation",
        "Pallidal deep brain stimulation: an effective treatment in Chinese patients with tardive dystonia",
        "Deep brain stimulation of the internal globus pallidus for disabling haloperidol-induced tardive dystonia. Report of two cases",
        "Forgotten but not gone: new developments in the understanding and treatment of tardive dyskinesia",
        "dyskinesia",
        "Tardive Dyskinesia-A Task Force Report of the American Psychiatric Association",
        "Neuroleptic withdrawal in schizophrenic patients. A review of the literature",
        "Brain-derived neurotrophic factor levels and its Val66Met gene polymorphism predict tardive dyskinesia treatment response to Ginkgo biloba",
        "Ginkgo biloba and cerebral bleeding: a case report and critical review",
        "A randomized controlled trial of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced tardive dyskinesia",
        "Olanzapine treatment for tardive dyskinesia in schizophrenia patients: a prospective clinical trial with patients randomized to blinded dose reduction periods",
        "Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study",
        "Effects of risperidone in tardive dyskinesia: an analysis of the Canadian multicenter risperidone study",
        "A controlled trial of amantadine hydrochloride and neuroleptics in the treatment of tardive dyskinesia",
        "Amantadine hydrochloride treatment of tardive dyskinesia",
        "Tardive dyskinesia in schizophrenic patients treated with psychotropic drugs",
        "Effects of amantadine on tardive dyskinesia: a randomized, double-blind, placebo-controlled study",
        "Treatment of tardive dyskinesia with bromocriptine. A test of the receptor modification strategy",
        "Clonazepam treatment of tardive dyskinesia: a practical GABAmimetic strategy",
        "Is diltiazem effective in treating the symptoms of (tardive) dyskinesia in chronic psychiatric inpatients? A negative, double-blind, placebo-controlled trial",
        "Diltiazem for tardive dyskinesia",
        "The effects of eicosapentaenoic acid in tardive dyskinesia: a randomized, placebo-controlled trial",
        "Treatment of tardive dyskinesia with galantamine: a randomized controlled crossover trial",
        "Extract of Ginkgo biloba treatment for tardive dyskinesia in schizophrenia: a randomized, double-blind, placebo-controlled trial",
        "A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients",
        "Clinical observations of the treatment of tardive dyskinesia with haloperidol",
        "Tardive dyskinesia during and following treatment with haloperidol, haloperidol\u202f+\u202fbiperiden, thioridazine, and clozapine",
        "Molindone and haloperidol in tardive dyskinesia",
        "Vitamin B(6) in the treatment of tardive dyskinesia: a double-blind, placebo-controlled, crossover study",
        "Vitamin B6 treatment for tardive dyskinesia: a randomized, double-blind, placebo-controlled, crossover study",
        "Vitamin E treatment for tardive dyskinesia. Veterans affairs cooperative study #394 study group",
        "Vitamin E treatment of tardive dyskinesia",
        "Treatment of tardive dyskinesia with vitamin E",
        "Vitamin E in the treatment of tardive dyskinesia",
        "Vitamin E in the treatment of tardive dyskinesia: a replication study",
        "A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia",
        "Tardive dyskinesia, lipid peroxidation, and sustained amelioration with vitamin E treatment",
        "Treatment of tardive dyskinesia with vitamin E",
        "Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled study",
        "alpha-Tocopherol treatment for tardive dyskinesia"
    ],
    "affiliation": [
        {
            "affiliation-city": "Tokyo",
            "@id": "60032116",
            "affilname": "Juntendo University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032116",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "New York",
            "@id": "60027565",
            "affilname": "Columbia University Irving Medical Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027565",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Providence",
            "@id": "60009796",
            "affilname": "The Warren Alpert Medical School",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009796",
            "affiliation-country": "United States"
        }
    ],
    "funding": [
        "Chulalongkorn Academic Advancement Fund",
        "International Research Network",
        "Chulalongkorn University",
        "National Research Council of Thailand"
    ]
}